New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:25 EDTDRRX, DRRX, PCRX, PCRXSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Durect's (DRRX) Posidur for post-operative pain, its safety and whether it could be disruptive to Pacira Pharmaceuticals (PCRX) on an Analyst/Industry conference call to be held on January 8 at 11 am.
News For DRRX;PCRX From The Last 14 Days
Check below for free stories on DRRX;PCRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
10:00 EDTPCRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:43 EDTPCRXPacira Pharmaceuticals initiated with a Buy at Jefferies
Target $81.
April 21, 2014
10:01 EDTPCRXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 2U (TWOU) initiated with a Buy at Compass Point... A10 Networks (ATEN) initiated with a Buy at Citigroup... Applied Genetic (AGTC) initiated with a Buy at Cantor... Ashford Hospitality Prime (AHP) initiated with a Hold at Deutsche Bank... Atmos Energy (ATO) initiated with a Neutral at JPMorgan... Navient (NAVIV) initiated with a Buy at Goldman... Pacira Pharmaceuticals (PCRX) initiated with a Buy at BofA/Merrill... Puma Biotechnology (PBYI) initiated with a Buy at Citigroup... Sallie Mae Bank (SLMVV) initiated with a Neutral at Goldman... Square 1 Financial (SQBK) initiated with a Market Perform at Keefe Bruyette.
06:14 EDTPCRXPacira Pharmaceuticals initiated with a Buy at BofA/Merrill
Target $86.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use